Performing Real-Time qPCR with the 5’ fluorogenic nuclease assay and a Double-Dye oligonucleotide probe provides additional specificity during PCR amplification, an essential component for a successful analysis. To save you valuable time, Eurogentec has developed FAST Probe MasterMixes, which contain a hotstart enzyme system specific for FAST quantitative PCR, and are fully compatible with two-step qRT-PCR reactions. Designed for ease-of-use and seamless integration with our Double-Dye oligonucleotide probes, these FAST MasterMixes enable more rapid screening of DNA and cDNA targets. Our new FAST MasterMixes deliver a significantly shorter run time than the standard MasterMixes without compromising the quality of the results. Sensitive and reproducible Real-Time results can be obtained in under 40 minutes for 40 cycles of PCR with a 20 µl-reaction volume using any FAST Real-Time PCR System.
In its constant search for innovative solutions, Eurogentec has combined its FAST MasterMixes with its new BLUE inert dye in one single product. The result is the new FAST BLUE qPCR kits for Probe Assays whose clearly visible blue color enables the status of MasterMix dispensing to be verified at a glance whilst enhancing performance with white PCR plastics. This ready-to-use, easy-to-see formulated mix, allows you to achieve the fastest and most sensitive results across all different FAST and non-FAST qPCR platforms and avoid aberrant results before they occur.
FAST and FAST BLUE qPCR kits are available now in a range of pack sizes and formulations and are compatible with every FAST Real-Time qPCR machine. Choose yours now! About EUROGENTEC
From its global headquarters in Liège, Belgium, EUROGENTEC has been a leading provider of innovative products and services to the Life Science, Diagnostic and Pharmaceutical communities for over 20 years. The company has distribution networks in over 40 countries and employs more than 300 people worldwide. The main cGMP oligo production site in Belgium is complemented by additional production facilities in the USA, Japan and Singapore providing B2B customers with overlapping manufacturing capabilities and harmonized methods, procedures and Quality Management Systems. In addition to GMP diagnostic oligonucleotide and antibody production, the parent company operates an authorized facility for the GMP manufacturing of biologics.
